Ground News

Don't Just Read the News, Understand It.

Eli Lilly image

News about Eli Lilly

Stay current with all the latest and breaking news about Eli Lilly, compare headlines and perspectives between news sources on stories happening today. In total, 350stories have been published about Eli Lilly which Ground News has aggregated in the past 3 months.

Covered Most By

themarketsdaily.com

watchlistnews.com

tickerreport.com

Suggest a source

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Eli Lilly News

Eli Lilly's Oral GLP-1 Pill Matches Injectables, Eyes Approval by Year-End

Pharma · United States

Eli Lilly's Oral GLP-1 Pill Matches Injectables, Eyes Approval by Year-End

64% Center coverage: 40 sources

Major Insurance Changes Are Coming for Weight Loss Drugs. Here’s How It Could Affect Patients

Eli Lilly · Milwaukee

Major Insurance Changes Are Coming for Weight Loss Drugs. Here’s How It Could Affect Patients

83% Center coverage: 30 sources

Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s what to know See the Story

Nektar Therapeutics Is Up 150%: What’s Happening With NKTR Stock?

Influenza · San Francisco

Nektar Therapeutics Is Up 150%: What’s Happening With NKTR Stock?

73% Center coverage: 11 sources

NKTR stock is up around 150% in today’s trading session following the recently announced positive results from its Phase 2b REZOLVE-AD study of rezpegaldesleukin for...See the Story

Ozempic in a pill? The next generation of weight-loss drugs emerges

50% Right coverage: 8 sources

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos lighter, she’s laughing.Ozempic See the Story

Medical Stocks To Keep An Eye On

100% Center coverage: 2 sources

UnitedHealth Group, Hims & Hers Health, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare sector, including pharmaceuticals, biotechnology, medicalEli Lilly See the Story

Pharmaceutical Stocks Worth Watching

100% Center coverage: 1 sources

Eli Lilly and Company, Merck & Co., Inc., D-Wave Quantum, Thermo Fisher Scientific, Pfizer, Honeywell International, and Becton, Dickinson and Company are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly tradStock Markets Read Article

Weight-loss drugs may not solve India’s obesity problem

100% Right coverage: 1 sources

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, introducing powerful GLP-1/GIP receptor agonists to tackle the nation's rising obesity and diabetes rates.Diabetes · India Read Article

How Novo Nordisk Misread the US Market for Its Weight Loss Sensation – RamaOnHealthcare

COPENHAGEN (Reuters) -Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of itsPharma · Denmark See the Story

Pharmaceutical Stocks Worth Watching

100% Center coverage: 1 sources

Eli Lilly and Company, Thermo Fisher Scientific, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are equity shares of companies that research, develop, manufacture and market prescription drugs and therapeutic treatStock Markets See the Story

Eli Lilly (LLY) Faces Bearish Options Flow, But Probabilities Tell a Different Story

Options traders leaned bearish on LLY stock, but market demand data reveals conditional odds that may support near-term upside.Stock Markets Read Article

Eli Lilly and Company (NYSE:LLY) Receives Average Rating of “Moderate Buy” from Brokerages

Eli Lilly and Company (NYSE:LLY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and sixteen have given a buy recommendation […]Eli Lilly · Indianapolis Read Article

Breaking News Topics Related to Eli Lilly